Healthcare firm Sanofi India on February 23 announced a substantial year-on-year profit growth of 45% to Rs 130.9 crore for the quarter ending December 2022, primarily driven by a strong operating performance.
However, revenue from operations for the quarter fell by 2.3 percent YoY to Rs 672 crore. The company follows the calendar year as its financial year.
The operating performance for the quarter was strong given the lower input cost. EBITDA (earnings before interest, tax, depreciation, and amortisation) in Q4CY22 grew by 31.2 percent to Rs 167 crore and the margin expanded by 635 bps to 24.84 percent compared to the corresponding period last fiscal.
Sanofi India's annual performance for the financial year ended December 2022 was weak, with a 34.3% decline in profit to Rs 620.6 crore and a 6.3% decrease in revenue to Rs 2,770 crore compared to the previous year. However, the company's quarterly performance for the last quarter of 2022 showed a strong operating performance, with a 45% YoY growth in profit to Rs 130.9 crore.
Cick Here To Read All Earnings Related News
Sanofi has announced a final dividend of Rs 194 per share (on the face value of Rs 10 each) and a second special dividend of Rs 183 per share for the financial year ended December 2022.
Earlier in August 2022, the company had paid a one-time special Interim Dividend of Rs 193 per share. With this, the total dividend for the financial year amounted to Rs 570 per share.